Numerous barriers hamper access to life-saving vaccines for millions of people living in the developing world. At our new global headquarters in Singapore, Hilleman Laboratories translates early discovery of vaccines and biologics for infectious diseases into affordable products with global health impact. Our focus on global health access means we prioritize effective delivery of high impact products and ensure wide access in under-served regions.
